These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 36680841
21. The failure of preoperative ethylene-vinyl alcohol copolymer embolization to improve outcomes in arteriovenous malformation management: case series. Morgan MK, Davidson AS, Koustais S, Simons M, Ritson EA. J Neurosurg; 2013 May; 118(5):969-77. PubMed ID: 23350776 [Abstract] [Full Text] [Related]
22. Results of Endovascular-First Approach for Treatment of Scalp Arteriovenous Malformations and the Effect of Simplified Angiographic Classification in Therapeutic Decision-Making and Outcomes. Gopinath M, Malik V, Sankara Sarma P, Rajan JE, Kannath SK. World Neurosurg; 2019 Jan; 121():e277-e286. PubMed ID: 30261380 [Abstract] [Full Text] [Related]
23. Pre-Surgical Endovascular Proximal Feeder Artery Devascularization Technique for the Treatment of Cranial Arteriovenous Malformations. Alawneh K, Abuzayed B, Al Qawasmeh M, Raffee L, Aleshawi A. Vasc Health Risk Manag; 2020 Jan; 16():181-191. PubMed ID: 32547045 [Abstract] [Full Text] [Related]
24. Intermixed Dimethyl-Sulfoxide-Based Nonadhesive Liquid Embolic Agents Delivered Serially via the Same Microcatheter for Cerebral AVM Treatment. Sirakov A, Minkin K, Sirakov S. AJNR Am J Neuroradiol; 2020 Apr; 41(4):681-686. PubMed ID: 32165357 [Abstract] [Full Text] [Related]
25. Investigation of a New Version of the Liquid Embolic Agent PHIL with Extra-Low-Viscosity in an Endovascular Embolization Model. Vollherbst DF, Otto R, Hantz M, Ulfert C, Kauczor HU, Bendszus M, Sommer CM, Möhlenbruch MA. AJNR Am J Neuroradiol; 2018 Sep; 39(9):1696-1702. PubMed ID: 30093480 [Abstract] [Full Text] [Related]
26. Combined therapy of cerebral arteriovenous malformations: histological differences between a non-adhesive liquid embolic agent and n-butyl 2-cyanoacrylate (NBCA). Duffner F, Ritz R, Bornemann A, Freudenstein D, Wiendl H, Siekmann R. Clin Neuropathol; 2002 Sep; 21(1):13-7. PubMed ID: 11846039 [Abstract] [Full Text] [Related]
27. Endovascular treatment of brain arteriovenous malformations using a liquid embolic agent: results of a prospective, multicentre study (BRAVO). Pierot L, Cognard C, Herbreteau D, Fransen H, van Rooij WJ, Boccardi E, Beltramello A, Sourour N, Kupcs K, Biondi A, Bonafé A, Reith W, Casasco A. Eur Radiol; 2013 Oct; 23(10):2838-45. PubMed ID: 23652849 [Abstract] [Full Text] [Related]
30. Endovascular embolization of canine hepatic arteriovenous malformations using precipitating hydrophobic injectable liquid (PHIL) liquid embolic agent: a proof of concept study. Ryan SD, Nambiar A, Maingard J, Kok HK, Turner RBS, Brooks DM, Asadi H. CVIR Endovasc; 2019 Aug 01; 2(1):27. PubMed ID: 32026126 [Abstract] [Full Text] [Related]
31. Extending Endovascular Embolization to Type A Spinal Perimedullary Arteriovenous Fistula Using Liquid Embolic Agent: Technical Nuances, Challenges and Initial Outcome. Malik V, Kannath SK, Rajan JE, Lukas J. World Neurosurg; 2018 Nov 01; 119():267-273. PubMed ID: 30118864 [Abstract] [Full Text] [Related]
35. Arteriovenous malformation in the brain: a theoretical study explaining the behavior of liquid embolic agents during endovascular treatment. Lv X, Wu Z, Li Y. Neuroradiol J; 2013 Dec 01; 26(6):661-8. PubMed ID: 24355185 [Abstract] [Full Text] [Related]